Items where Division is "Faculties (pre 2018 reorg) > Faculty of Medicine (pre 2018 reorg) > Cancer Sciences (pre 2018 reorg) > Southampton Clinical Trials Unit (pre 2018 reorg)" and Year is 2015
 | Up a level |
Number of items: 14.
Utility of baseline 18FDG-PET/CT functional parameters in defining prognosis of primary mediastinal (thymic) large B-cell lymphoma - Luca Ceriani, Maurizio Martelli, Pier Luigi Zinzani, Andrés J.M. Ferreri, Barbara Botto, Caterina Stelitano, Manuel Gotti, Maria Giuseppina Cabras, Luigi Rigacci, Livio Gargantini, Francesco Merli, Graziella Pinotti, Donato Mannina, Stefano Luminari, Anastasios Stathis, Eleonora Russo, Franco Cavalli, Luca Giovanella, Peter W.M. Johnson and Emanuele Zucca
Type: Article
| 2015
| Item not available on this server.
Obesity and the outcome of young breast cancer patients in the UK: the POSH study - E.R. Copson, R.I. Cutress, T. Maishman, Bryony Kathryn Eccles, S. Gerty, L. Stanton, D.G. Altman, L. Durcan, C. Wong, P.D. Simmonds, L. Jones and Diana Eccles
Type: Article
| 2015
| Item not available on this server.
Understanding of BRCA VUS genetic results by breast cancer specialists - B K Eccles, E Copson, T Maishman, J E Abraham and D M Eccles
Type: Article
| 2015
Family history and outcome of young patients with breast cancer in the UK (POSH study) - B.K. Eccles, E.R. Copson, R. Cutress, T. Maishman, D.G. Altman, P. Simmonds, S. Gerty, L. Durcan, L. Stanton and D.M. Eccles
Type: Article
| 2015
| Item not available on this server.
SUCCINCT: An open-label, single-arm, non-randomised, phase 2 trial of gemcitabine and cisplatin chemotherapy in combination with Sunitinib as first-line treatment for patients with advanced urothelial carcinoma - Thomas Geldart, John Chester, Angela Casbard, Simon Crabb, Tony Elliott, Andrew Protheroe, Robert A. Huddart, Graham Mead, Jim Barber, Robert J. Jones, Joanna Smith, Robert Cowles, Jessica Evans and Gareth Griffiths
Type: Article
| 2015
Health-related quality of Life in SCALOP, a randomized phase 2 trial comparing chemoradiation therapy regimens in locally advanced pancreatic cancer - Christopher N. Hurt, Somnath Mukherjee and John Bridgewater
Type: Article
| 2015
Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy - Jieping Lei, Anja Rudolph, Kirsten B. Moysich, Sajjad Rafiq, Sabine Behrens, Ellen L. Goode, Paul P.D. Pharoah, Petra Seibold, Peter A. Fasching, Irene L. Andrulis, Vessela N. Kristensen, Fergus J. Couch, Ute Hamann, Maartje J. Hooning, Heli Nevanlinna, Ursula Eilber, Manjeet K. Bolla, Joe Dennis, Qin Wang, Annika Lindblom, Arto Mannermaa, Diether Lambrechts, Montserrat García-Closas, Per Hall, Georgia Chenevix-Trench, Mitul Shah, Robert Luben, Lothar Haeberle, Arif B. Ekici, Matthias W. Beckmann, Julia A Knight, Gord Glendon, Sandrine Tchatchou, Grethe I. Grenaker Alnæs, Anne-Lise Borresen-Dale, Silje Nord, Janet E. Olson, Emily Hallberg, Celine Vachon, Diana Torres, Hans-Ulrich Ulmer, Thomas Rüdiger, Agnes Jager, Carolien H.M. van Deurzen, Madeleine M.A. Tilanus-Linthorst, Taru A. Muranen, Kristiina Aittomäki, Tom Maishman, William J. Tapper and Diana Eccles
Type: Article
| 2015
| Item not available on this server.
An evaluation of the prognostic model PREDICT using the POSH cohort of women aged ⩽40 years at breast cancer diagnosis - T. Maishman, E. Copson, L. Stanton, S. Gerty, E. Dicks, L. Durcan, G.C. Wishart, P. Pharoah and D. Eccles
Type: Article
| 2015
NEOSCOPE: a randomised Phase II study of induction chemotherapy followed by either oxaliplatin/capecitabine or paclitaxel/carboplatin based chemoradiation as pre-operative regimen for resectable oesophageal adenocarcinoma - Somnath Mukherjee, Christopher N. Hurt, Sarah Gwynne, Andrew Bateman, Simon Gollins, Ganesh Radhakrishna, Maria Hawkins, Jo Canham, Wyn Lewis, Heike I. Grabsch, Ricky A. Sharma, Wendy Wade, Rhydian Maggs, Bethan Tranter, Ashley Roberts, David Sebag-Montefiore, Timothy Maughan, Gareth Griffiths and Tom Crosby
Type: Article
| 2015
| Item not available on this server.
Cetuximab is contraindicated in the perioperative treatment of colorectal liver metastases - John N. Primrose, David Cunningham, O. James Garden, Tim S. Maughan, Siân A. Pugh, Louise Stanton, Stephen J. Falk, Myrddin Rees, Meg Finch-Jones, Juan W. Valle, Derek O'Reilly, Joanne Hornbuckle, Tamas Hickish and John A. Bridgewater
Type: Article
| 2015
| Item not available on this server.
Clinical trial metadata: defining and extracting metadata on the design, conduct, results and costs of 125 randomised clinical trials funded by the National Institute for Health Research Health Technology Assessment programme - James Raftery, Amanda Young, Louise Stanton, Ruairidh Milne, Andrew Cook, David Turner and Peter Davidson
Type: Article
| 2015
Patient-reported outcomes during and after definitive chemoradiotherapy for oesophageal cancer - J. Rees, C.N. Hurt and S. Gollins
Type: Article
| 2015
The clinical effectiveness and cost-effectiveness of STeroids Or Pentoxifylline for Alcoholic Hepatitis (STOPAH): a 2 × 2 factorial randomised controlled trial - Mark Thursz, Ewan Forrest, Paul Roderick, Christopher Day, Andrew Austin, John O'Grady, Stephen Ryder, Michael Allison, Dermot Gleeson, Anne McCune, David Patch, Mark Wright, Steven Masson, Paul Richardson, Luke Vale, Jane Mellor, Louise Stanton, Megan Bowers, Ian Ratcliffe, Nichola Downs, Scott Kirkman, Tara Homer and Laura Ternent
Type: Article
| 2015
| Item not available on this server.
Prednisolone or pentoxifylline for alcoholic hepatitis - Mark R. Thursz, Paul Richardson, Michael Allison, Andrew Austin, Megan Bowers, Christopher P. Day, Nichola Downs, Dermot Gleeson, Alastair MacGilchrist, Allister Grant, Steven Hood, Steven Masson, Anne McCune, Jane Mellor, John O’Grady, David Patch, Ian Ratcliffe, Paul Roderick, Louise Stanton, Nikhil Vergis, Mark Wright, Stephen Ryder and Ewan H. Forrest
Type: Article
| 2015
| Item not available on this server.